Доксазозин мезилат активный фармацевтический ингредиент EP CAS № 77883 43 3

Doxazosin Mesylate is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph.
Its CAS-Ndeg reads 77883-43-3.
It is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia - BPH. Doxazosin mesylate is a selective alpha-blocker that selectively binds to alpha1-receptors, thus dilating peripheral blood vessels. This reduces blood pressure and cholesterol levels of the serum.
Detailed specification, Certificate of Analysis and samples are available on request.

Characteristics:

Pictures:

We offer various payment options. Please contact us for futher details.

1. Our products are packed according to the international export packing standards for seaworthy packing: carton box, plastic bag, wooden or iron/steel pallet or container.


2. We can also deliver our products carefully packed according to customer requirement. Please contact us for getting further details.


3. Packaging includes the full set of documents and (if necessary) operate maintenance and engine operate manual, spare parts list and set of inspection certificate issued by manufacturer.

Midas Pharma GmbH

//ky.to/www.midas-pharma.com

Providing products and services across the full pharmaceutical value chain, Midas Pharma is a mid-sized company with 250 highly qualified employees that provides a wealth of expertise while connecting companies, people and knowledge. As a catalyst for collaboration, we have been supporting our clients and partners unlock untapped potential for more than 30 years. Active in all major pharmaceutical markets, our affiliates serve as points of contact for our local customers as well as development and supply partners. They also provide local competence and networks.

Midas is active in sourcing, supplying and developing finished products, active ingredients and intermediates. In addition, we offer services in:

Custom synthesis
Biotechnology
Finished product development
Finished product manufacturing
Regulatory affairs
Quality management
Patents and intellectual property
Business development and licensing
Business Process Outsourcing
Distribution and Warehousing

We create value by offering a wealth of expertise while coordinating and connecting the complementary parts — people, knowledge and resources — to facilitate global pharmaceutical projects. For laboratory and production work, we cooperate with carefully selected specialist partners. This approach is the key to our flexibility in creating solutions through a wide array of services.